The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Andreychenko S.A.

Federal Scientific Clinical Center for Specialized Medical Care and Medical Technologies, FMBA of Russia, Moscow, Russia

Sukonnikov T.A.

Federal Scientific Clinical Center for Specialized Medical Care and Medical Technologies, FMBA of Russia, Moscow, Russia

Bychinin M.V.

Federal Scientific Clinical Center for Specialized Medical Care and Medical Technologies, FMBA of Russia, Moscow, Russia

Klypa T.V.

Federal Scientific Clinical Center for Specialized Medical Care and Medical Technologies, FMBA of Russia, Moscow, Russia

Difficulties in the diagnosis of acute porphyria: case report

Authors:

Andreychenko S.A., Sukonnikov T.A., Bychinin M.V., Klypa T.V.

More about the authors

Read: 5260 times


To cite this article:

Andreychenko SA, Sukonnikov TA, Bychinin MV, Klypa TV. Difficulties in the diagnosis of acute porphyria: case report. Russian Journal of Anesthesiology and Reanimatology. 2019;(3):90‑96. (In Russ.)
https://doi.org/10.17116/anaesthesiology201903190

Recommended articles:
Main dire­ctions in corneal nerve fibers research. Russian Annals of Ophthalmology. 2024;(6):118-124
Neurological complications resu­lting of nitrous oxide into­xication. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(12):41-46

References:

  1. Savchenko VG. Programmnoe lechenie zabolevanij sistemy krovi. M.: Praktika, 2012. (In Russ.)
  2. Levin OS. «Owls are not what they seem»: the difficulty of diagnosis and treatment of neurological manifestations of porphyria. Sovremennaya terapiya v psihiatrii i nevrologii. 2017;4:4-13. (In Russ.)
  3. Smagina IV, Yurchenko YuN, Mersiyanova LV, Elchaninova SA, Elchaninov DV. Challenges in diagnosis of nervous system impairment in porphyria. Nevrologicheskiy Zhurnal. 2016;21(5):299-304. (In Russ.)
  4. Anderson KE, Bloomer JR, Bonkovsky HL, Kushner JP, Pierach CA, Pimstone NR. Recommendations for the diagnosis and treatment of the acute porphyrias. American College of Physicians; 2005;142(6):439. doi: 10.7326/0003-4819-142-6-200503150-00010
  5. Whatley SD, Badminton MN. Acute intermittent porphyria. In: Pagon RA, Adam MP, Ardinger HH, Bird TD, Dolan CR, Fong CT, Smith RJH, Stephens K, eds. Gene Reviews. Seattle: University of Washington, 2013.
  6. Elder GH, Sandberg S. Identifying acute porphyria in patients with acute polyneuropathy or encephalopathy. Nature Clinical Practice Neurology. 2008;4(12):648-649. doi: 10.1038/ncpneuro0946
  7. Pustovoyt YaS, Galstyan GM, Savchenko VG. Diagnostic role of some syndromes and symptoms in the semeiotics of acute porphyrias. Gematologiya i transfuziologiya. 2014;59(3):35-39. (In Russ.)
  8. Stölzel U, Kubisch I, Stauch T. Porphyrien — was ist gesichert? Der Internist. Springer Nature; 2018;59(12):1239-1248. doi: 10.1007/s00108-018-0509-z
  9. Balwani M, Wang B, Anderson KE, Bloomer JR, Bissell DM, Bonkovsky HL, Phillips JD, Desnick RJ; Porphyrias Consortium of the Rare Diseases Clinical Research Network. Acute hepatic porphyrias: Recommendations for evaluation and long-term management. Hepatology. 2017;66(4):1314-1322. doi: 10.1002/hep.29313
  10. Mykletun M, Aarsand AK, Støle E, Villanger JH, Tollånes MC, Baravelli C, Sandberg S. Porfyrisykdommer i Norge. Tidsskrift for Den Norske Legeforening. Journal of the Norwegian Medical Association. 2014;134(8):831-835. doi: 10.4045/tidsskr.13.0649
  11. Innala E, Bäckström T, Bixo M, Andersson C. Evaluation of gonadotropin-releasing hormone agonist treatment for prevention of menstrual-related attacks in acute porphyria. Acta Obstetricia et Gynecologica Scandinavica. 2010;89(1):95-100. doi: 10.3109/00016340903390729
  12. O’Malley R, Rao G, Stein P, Bandmann O. Porphyria: often discussed but too often missed. Practical Neurology. 2018;18(5):352-358. doi: 10.1136/practneurol-2017-001878
  13. Schmitt C, Lenglet H, Yu A, Delaby C, Benecke A, Lefebvre T, Letteron P, Paradis V, Wahlin S, Sandberg S, Harper P, Sardh E, Sandvik AK, Hov JR, Aarsand AK, Chiche L, Bazille C, Scoazec JY, To-Figueras J, Carrascal M, Abian J, Mirmiran A, Karim Z, Deybach JC, Puy H, Peoc’h K, Manceau H, Gouya L. Recurrent attacks of acute hepatic porphyria: major role of the chronic inflammatory response in the liver. Journal of Internal Medicine. 2018;284(1):78-91. doi: 10.1111/joim.12750
  14. Simon NG, Herkes GK. The neurologic manifestations of the acute porphyrias. Journal of Clinical Neuroscience. 2011;18(9):1147-1153. doi: 10.1016/j.jocn.2011.01.003
  15. Wu C-L, Ro L-S, Jung S-M, Tsai T-C, Chu C-C, Lyu R-K, Huang CC, Kuo HC. Clinical presentation and electrophysiological findings of porphyric neuropathies: A follow-up study. Muscle & Nerve. 2015;51(3):363-369. doi: 10.1002/mus.24327
  16. Pandey CK, Raza M, Tripathi M, Navkar DV, Kumar A, Singh UK. The Comparative Evaluation of Gabapentin and Carbamazepine for Pain Management in Guillain-Barré Syndrome Patients in the Intensive Care Unit. Anesthesia & Analgesia. 2005;101(1):220-225. doi: 10.1213/01.ane.0000152186.89020.36
  17. Belkin AA, Alasheev AM, Lejderman IN, Lubnin AYu, Petrikov SS, Suvorov AYu, i dr. Reabilitaciya v Intensivnoj terapii. Klinicheskie rekomendatsii Federatsii anesteziologov-reanimatologov Rossiyskoy Federatsii. 2015. (In Russ.)
  18. Savust’yanenko AV. Use of carbamazepine for the treatment of neuropathic pain: a review of studies. Mezhdunarodnyy nevrologicheskiy zhurnal. 2011;2:107-115. (In Russ.)
  19. Spasovski G, Vanholder R, Allolio B, Annane D, Ball S, Bichet D, Decaux G, Fenske W, Hoorn EJ, Ichai C, Joannidis M, Soupart A, Zietse R, Haller M, van der Veer S, Van Biesen W, Nagler E; Hyponatraemia Guideline Development Group. Clinical practice guideline on diagnosis and treatment of hyponatraemia. European Journal of Endocrinology. 2014;170(3):G1-G47. doi: 10.1530/eje-13-1020
  20. Bissell DM, Anderson KE, Bonkovsky HL. Porphyria. New England Journal of Medicine. 2017;377(9):862-872. doi: 10.1056/nejmra1608634
  21. Puy H, Deybach JC, Lamoril J, Robreau AM, Da Silva V, Gouya L, Grandchamp B, Nordmann Y. Molecular Epidemiology and Diagnosis of PBG Deaminase Gene Defects in Acute Intermittent Porphyria. The American Journal of Human Genetics. 1997;60(6):1373-1383. doi: 10.1086/515455
  22. Andersson C, Thunell S, Floderus Y, Forsell C, Lundin G, Anvret M, Lannfelt L, Wetterberg L, Lithner F. Diagnosis of acute intermittent porphyria in northern Sweden: an evaluation of mutation analysis and biochemical methods. Journal of Internal Medicine. 1995;237(3):301-308. doi: 10.1111/j.1365-2796.1995.tb01179.x
  23. Pustovoyt YaS, Kravchenko SK, Shmakov RG, Savchenko VG. Diagnostika i lechenie ostrykh porfiriy. Natsional’nye klinicheskie rekomendatsi. 2018. (In Russ.)
  24. Dhital R, Basnet S, Poudel DR, Bhusal KR. Acute intermittent porphyria: a test of clinical acumen. Journal of Community Hospital Internal Medicine Perspectives. 2017;7(2):100-102. doi: 10.1080/20009666.2017.1317535
  25. Cardenas JL, Guerrero C. Acute intermittent porphyria: general aspects with focus on pain. Current Medical Research and Opinion. 2018;1-7. doi: 10.1080/03007995.2018.1435521
  26. Besur S, Hou W, Schmeltzer P, Bonkovsky H. Clinically Important Features of Porphyrin and Heme Metabolism and the Porphyrias. Metabolites. 2014;4(4):977-1006. doi: 10.3390/metabo4040977
  27. Thunell S, Pomp E, Brun A. Guide to drug porphyrogenicity prediction and drug prescription in the acute porphyrias. British Journal of Clinical Pharmacology. 2007;64(5):668-679. doi: 10.1111/j.0306-5251.2007.02955.x
  28. Pustovoyt YaS, Surin VL, Zingerman BV, Gorgidze LA, Gemdzhjan JeG, Galstyan GM. Russian register of medicines used in patients with porphyria’s metabolism disorders. Gematologiya i transfuziologiya. 2015;60(3):38-43. (In Russ.)
  29. Pustovoyt YaS. Federal’nye klinicheskie rekomendatsii po diagnostike i lecheniyu ostrykh porfiriy. 2013. (In Russ.)
  30. Bonkovsky HL, Maddukuri VC, Yazici C, Anderson KE, Bissell DM, Bloomer JR, Phillips JD, Naik H, Peter I, Baillargeon G, Bossi K, Gandolfo L, Light C, Bishop D, Desnick RJ. Acute Porphyrias in the USA: Features of 108 Subjects from Porphyrias Consortium. The American Journal of Medicine. 2014;127(12):1233-1241. doi: 10.1016/j.amjmed.2014.06.036
  31. Singal AK, Parker C, Bowden C, Thapar M, Liu L, McGuire BM. Liver transplantation in the management of porphyria. Hepatology. 2014;60(3):1082-1089. doi: 10.1002/hep.27086
  32. Naik H, Stoecker M, Sanderson SC, Balwani M, Desnick RJ. Experiences and concerns of patients with recurrent attacks of acute hepatic porphyria: A qualitative study. Molecular Genetics and Metabolism. 2016;119(3):278-283. doi: 10.1016/j.ymgme.2016.08.006
  33. Stein P, Badminton M, Barth J, Rees D, Stewart MF. Best practice guidelines on clinical management of acute attacks of porphyria and their complications. Annals of Clinical Biochemistry. 2013;50(3):217-223. doi: 10.1177/0004563212474555
  34. Pischik E, Kauppinen R. An update of clinical management of acute intermittent porphyria. The Application of Clinical Genetics. 2015;201. doi: 10.2147/tacg.s48605
  35. Eremenko AA, Zyulyaeva TP, Bozh’eva LV. Principles of preventing pneumonia associated with the use of mechanical ventilation in the intensive care unit. Anesteziologiya i reanimatologiya. 2001;2:16-19. (In Russ.)

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.